17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Methohexital.
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Methohexital is combined with Gamma Hydroxybutyric Acid.
Acebutolol
The serum concentration of Acebutolol can be decreased when it is combined with Methohexital.
Advertisement
Acenocoumarol
The metabolism of Acenocoumarol can be increased when combined with Methohexital.
Acepromazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Aceprometazine.
Advertisement
Acetaminophen
The metabolism of Acetaminophen can be increased when combined with Methohexital.
Aldesleukin
Methohexital may increase the hypotensive activities of Aldesleukin.
Alfaxalone
The risk or severity of adverse effects can be increased when Methohexital is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Methohexital is combined with Alfentanil.
Aliskiren
Methohexital may increase the hypotensive activities of Aliskiren.
Alphaprodine
The risk or severity of adverse effects can be increased when Methohexital is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Methohexital.
Alprenolol
The serum concentration of Alprenolol can be decreased when it is combined with Methohexital.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Methohexital.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Methohexital.
Amifostine
Methohexital may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Methohexital may increase the hypotensive activities of Amifostine.
Amiloride
Methohexital may increase the hypotensive activities of Amiloride.
Amineptin
The metabolism of Amineptine can be increased when combined with Methohexital.
Aminophylline
The serum concentration of Aminophylline can be decreased when it is combined with Methohexital.
Amiodarone
Methohexital may increase the hypotensive activities of Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Methohexital is combined with Amisulpride.
Amitriptyline
The metabolism of Amitriptyline can be increased when combined with Methohexital.
Amlodipine
The metabolism of Amlodipine can be increased when combined with Methohexital.
Amobarbital
The risk or severity of adverse effects can be increased when Methohexital is combined with Amobarbital.
Amoxapine
The metabolism of Amoxapine can be increased when combined with Methohexital.
Amphotericin B
Methohexital may increase the hypotensive activities of Amphotericin B.
amphotericin B liposomal
Methohexital may increase the hypotensive activities of Amphotericin B.
Amyl Nitrite
Methohexital may increase the hypotensive activities of Amyl Nitrite.
Apomorphine
Methohexital may increase the hypotensive activities of Apomorphine.
Apraclonidine
Methohexital may increase the hypotensive activities of Apraclonidine.
Aripiprazole
The risk or severity of adverse effects can be increased when Methohexital is combined with Aripiprazole.
Arsenic Trioxide
Methohexital may increase the hypotensive activities of Arsenic trioxide.
Articaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Methohexital is combined with Asenapine.
Atenolol
The serum concentration of Atenolol can be decreased when it is combined with Methohexital.
Azelastine
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azilsartan
Methohexital may increase the hypotensive activities of Azilsartan medoxomil.
Azilsartan kamedoxomil
Methohexital may increase the hypotensive activities of Azilsartan medoxomil.
Azilsartan Medoxomil
Methohexital may increase the hypotensive activities of Azilsartan medoxomil.
Baclofen
The risk or severity of adverse effects can be increased when Methohexital is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Methohexital is combined with Barbital.
Benazepril
Methohexital may increase the hypotensive activities of Benazepril.
Bencyclane
The metabolism of Bencyclane can be increased when combined with Methohexital.
Bendroflumethiazide
Methohexital may increase the orthostatic hypotensive activities of Bendroflumethiazide.
Benoxinate
The risk or severity of adverse effects can be increased when Methohexital is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Methohexital is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Benzocaine.
Benzthiazide
Methohexital may increase the orthostatic hypotensive activities of Benzthiazide.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Methohexital is combined with Benzyl alcohol.
Bepridil
The metabolism of Bepridil can be increased when combined with Methohexital.
Betaxolol
The serum concentration of Betaxolol can be decreased when it is combined with Methohexital.
Bioallethrin
The metabolism of Bioallethrin can be increased when combined with Methohexital.
Bisoprolol
The serum concentration of Bisoprolol can be decreased when it is combined with Methohexital.
Bopindolol
The serum concentration of Bopindolol can be decreased when it is combined with Methohexital.
Bortezomib
Methohexital may increase the hypotensive activities of Bortezomib.
Bretylium
Methohexital may increase the hypotensive activities of Bretylium.
Brexpiprazole
The risk or severity of adverse effects can be increased when Methohexital is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Bromazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Bromazepam.
Bromocriptine
Methohexital may increase the hypotensive activities of Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Methohexital is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Methohexital is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Methohexital is combined with Brotizolam.
Bumetanide
Methohexital may increase the hypotensive activities of Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Bupivacaine.
Bupranolol
The serum concentration of Bupranolol can be decreased when it is combined with Methohexital.
Buprenorphine
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Methohexital is combined with Buspirone.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Methohexital.
Butalbital
The risk or severity of adverse effects can be increased when Methohexital is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Methohexital is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Methohexital is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Methohexital is combined with Butorphanol.
Butriptyline
The metabolism of Butriptyline can be increased when combined with Methohexital.
Canagliflozin
Methohexital may increase the hypotensive activities of Canagliflozin.
Canagliflozin Anhydrous
Methohexital may increase the hypotensive activities of Canagliflozin.
Candesartan Cilexetil
Methohexital may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Methohexital may increase the hypotensive activities of Captopril.
Carbamazepine
The risk or severity of adverse effects can be increased when Methohexital is combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Methohexital is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Methohexital is combined with Carisoprodol.
Carteolol
The serum concentration of Carteolol can be decreased when it is combined with Methohexital.
Carvedilol
The serum concentration of Carvedilol can be decreased when it is combined with Methohexital.
Celiprolol
The serum concentration of Celiprolol can be decreased when it is combined with Methohexital.
Cetirizine
The risk or severity of adverse effects can be increased when Methohexital is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Methohexital is combined with Chloral hydrate.
Chloramphenicol
The metabolism of Methohexital can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Methohexital is combined with Chlordiazepoxide.
Chlormethiazole
The risk or severity of adverse effects can be increased when Methohexital is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Methohexital is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Chloroprocaine.
Chlorothiazide
Methohexital may increase the orthostatic hypotensive activities of Chlorothiazide.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Methohexital is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Methohexital is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Methohexital is combined with Chlorprothixene.
Chlorthalidone
Methohexital may increase the orthostatic hypotensive activities of Chlorthalidone.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Methohexital is combined with Chlorzoxazone.
Cilazapril
Methohexital may increase the hypotensive activities of Cilazapril.
Cinnarizine
The metabolism of Cinnarizine can be increased when combined with Methohexital.
Citalopram
The risk or severity of adverse effects can be increased when Methohexital is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Methohexital is combined with Clemastine.
Clevidipine
The metabolism of Clevidipine can be increased when combined with Methohexital.
Clevidipine butyrate
The metabolism of Clevidipine can be increased when combined with Methohexital.
Clidinium
The risk or severity of adverse effects can be increased when Methohexital is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Methohexital is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Methohexital is combined with Clobazam.
Clofarabine
Methohexital may increase the hypotensive activities of Clofarabine.
Clomipramine
The metabolism of Clomipramine can be increased when combined with Methohexital.
Clonazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Methohexital is combined with Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Methohexital is combined with Clorazepate.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Methohexital is combined with Clorazepate.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Methohexital.
Cocaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Methohexital.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Methohexital.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Methohexital.
Conivaptan
Methohexital may increase the hypotensive activities of Conivaptan.
Cyclandelate
The metabolism of Cyclandelate can be increased when combined with Methohexital.
Cyclizine
The risk or severity of adverse effects can be increased when Methohexital is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Methohexital is combined with Cyclobenzaprine.
Cyclopenthiazide
Methohexital may increase the orthostatic hypotensive activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Cyclosporine can be increased when combined with Methohexital.
Cyproheptadine
The risk or severity of adverse effects can be increased when Methohexital is combined with Cyproheptadine.
Cyproterone Acetate
The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Methohexital.
Dantrolene
The risk or severity of adverse effects can be increased when Methohexital is combined with Dantrolene.
Dapagliflozin
Methohexital may increase the hypotensive activities of Dapagliflozin.
Dapiprazole
The risk or severity of adverse effects can be increased when Methohexital is combined with Dapiprazole.
Desflurane
The risk or severity of adverse effects can be increased when Methohexital is combined with Desflurane.
Desipramine
The metabolism of Desipramine can be increased when combined with Methohexital.
Desloratadine
The risk or severity of adverse effects can be increased when Methohexital is combined with Desloratadine.
Desogestrel
The therapeutic efficacy of Desogestrel can be decreased when used in combination with Methohexital.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Methohexital is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of sedation and somnolence can be increased when Methohexital is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Methohexital is combined with Dexbrompheniramine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Methohexital is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Methohexital is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Methohexital is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Diazepam.
Dibucaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Cinchocaine.
Dichlorphenamide
Methohexital may increase the hypotensive activities of Diclofenamide.
Dicumarol
The metabolism of Dicoumarol can be increased when combined with Methohexital.
Dienogest
The therapeutic efficacy of Dienogest can be decreased when used in combination with Methohexital.
Diethylstilbestrol
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Methohexital.
Difenoxin
The risk or severity of adverse effects can be increased when Methohexital is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Methohexital is combined with Dihydrocodeine.
Diltiazem
The metabolism of Diltiazem can be increased when combined with Methohexital.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Methohexital is combined with Dimenhydrinate.
Dinutuximab
Methohexital may increase the hypotensive activities of Dinutuximab.
Diphenhydramine
The risk or severity of adverse effects can be increased when Methohexital is combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Methohexital is combined with Diphenoxylate.
Dipyridamole
Methohexital may increase the hypotensive activities of Dipyridamole.
Dothiepin
The metabolism of Dosulepin can be increased when combined with Methohexital.
Doxazosin
Methohexital may increase the hypotensive activities of Doxazosin.
Doxepin
The metabolism of Doxepin can be increased when combined with Methohexital.
Doxycycline
The serum concentration of Doxycycline can be decreased when it is combined with Methohexital.
Doxycycline Anhydrous
The serum concentration of Doxycycline can be decreased when it is combined with Methohexital.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Drospirenone
The therapeutic efficacy of Drospirenone can be decreased when used in combination with Methohexital.
Duloxetine
The risk or severity of adverse effects can be increased when Methohexital is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Methohexital is combined with Dyclonine.
Dyphylline
The serum concentration of Dyphylline can be decreased when it is combined with Methohexital.
Efavirenz
The risk or severity of adverse effects can be increased when Methohexital is combined with Efavirenz.
Empagliflozin
Methohexital may increase the hypotensive activities of Empagliflozin.
Enalapril
Methohexital may increase the hypotensive activities of Enalapril.
Enalaprilat
Methohexital may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Methohexital may increase the hypotensive activities of Enalaprilat.
Enflurane
The risk or severity of adverse effects can be increased when Methohexital is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Methohexital is combined with Entacapone.
Eplerenone
Methohexital may increase the hypotensive activities of Eplerenone.
Epoprostenol
Methohexital may increase the hypotensive activities of Epoprostenol.
Eprosartan
Methohexital may increase the hypotensive activities of Eprosartan.
Escitalopram
The risk or severity of adverse effects can be increased when Methohexital is combined with Escitalopram.
Esmolol
The serum concentration of Esmolol can be decreased when it is combined with Methohexital.
Estazolam
The risk or severity of adverse effects can be increased when Methohexital is combined with Estazolam.
Estradiol
The therapeutic efficacy of Estradiol can be decreased when used in combination with Methohexital.
Estradiol Cypionate
The therapeutic efficacy of Estradiol cypionate can be decreased when used in combination with Methohexital.
Estradiol Valerate
The therapeutic efficacy of Estradiol valerate can be decreased when used in combination with Methohexital.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methohexital.
Ethacrynate
Methohexital may increase the hypotensive activities of Etacrynic acid.
Ethacrynic Acid
Methohexital may increase the hypotensive activities of Etacrynic acid.
Ethanol
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Methohexital is combined with Ethchlorvynol.
Ethinyl Estradiol
The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Methohexital.
Ethosuximide
The risk or severity of adverse effects can be increased when Methohexital is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Methohexital is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Methohexital is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Methohexital is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Methohexital is combined with Ethylmorphine.
Ethynodiol Diacetate
The therapeutic efficacy of Ethynodiol diacetate can be decreased when used in combination with Methohexital.
Etidocaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Methohexital is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Methohexital is combined with Etomidate.
Etonogestrel
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Methohexital.
Ezogabine
The risk or severity of adverse effects can be increased when Methohexital is combined with Ezogabine.
Felbamate
The serum concentration of Methohexital can be increased when it is combined with Felbamate.
Felodipine
The metabolism of Felodipine can be increased when combined with Methohexital.
Fendiline
The metabolism of Fendiline can be increased when combined with Methohexital.
Fenoldopam
Methohexital may increase the hypotensive activities of Fenoldopam.
Fentanyl
The risk or severity of adverse effects can be increased when Methohexital is combined with Fentanyl.
Fexofenadine
The risk or severity of adverse effects can be increased when Methohexital is combined with Fexofenadine.
Fish Oils
The metabolism of Fish oil can be increased when combined with Methohexital.
Flibanserin
The risk or severity of adverse effects can be increased when Methohexital is combined with Flibanserin.
Fluindione
The metabolism of Fluindione can be increased when combined with Methohexital.
Flunarizine
The metabolism of Flunarizine can be increased when combined with Methohexital.
Flunitrazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Methohexital is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Methohexital is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Fluphenazine.
Flurazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Flurazepam.
Fluspirilene
The risk or severity of adverse effects can be increased when Methohexital is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Methohexital is combined with Fluticasone propionate.
Fluvoxamine
The risk or severity of adverse effects can be increased when Methohexital is combined with Fluvoxamine.
Fosinopril
Methohexital may increase the hypotensive activities of Fosinopril.
Fosphenytoin
The risk or severity of adverse effects can be increased when Methohexital is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Methohexital is combined with Fospropofol.
Furosemide
Methohexital may increase the hypotensive activities of Furosemide.
Gabapentin
The risk or severity of adverse effects can be increased when Methohexital is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Methohexital is combined with Gabapentin Enacarbil.
Gallopamil
The metabolism of Gallopamil can be increased when combined with Methohexital.
Gestodene
The therapeutic efficacy of Gestodene can be decreased when used in combination with Methohexital.
Gestrinone
The therapeutic efficacy of Gestrinone can be decreased when used in combination with Methohexital.
Glutethimide
The risk or severity of adverse effects can be increased when Methohexital is combined with Glutethimide.
Griseofulvin
The serum concentration of Griseofulvin can be decreased when it is combined with Methohexital.
Griseofulvin microsize
The serum concentration of Griseofulvin can be decreased when it is combined with Methohexital.
Guanfacine
The risk or severity of adverse effects can be increased when Methohexital is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Methohexital is combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Methohexital is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Methohexital is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Methohexital is combined with Hexobarbital.
Hydralazine
Methohexital may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Methohexital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Hydrocodone
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroflumethiazide
Methohexital may increase the orthostatic hypotensive activities of Hydroflumethiazide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methohexital.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Methohexital.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Iloperidone
The risk or severity of adverse effects can be increased when Methohexital is combined with Iloperidone.
Iloprost
Methohexital may increase the hypotensive activities of Iloprost.
Imidapril
Methohexital may increase the hypotensive activities of Imidapril.
Imipramine
The metabolism of Imipramine can be increased when combined with Methohexital.
Inamrinone
The metabolism of Amrinone can be increased when combined with Methohexital.
Indapamide
Methohexital may increase the orthostatic hypotensive activities of Indapamide.
Indoramin
Methohexital may increase the hypotensive activities of Indoramin.
Irbesartan
Methohexital may increase the hypotensive activities of Irbesartan.
Isocarboxazid
Methohexital may increase the hypotensive activities of Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Methohexital is combined with Isoflurane.
Isosorbide Dinitrate
Methohexital may increase the hypotensive activities of Isosorbide Dinitrate.
Isosorbide Mononitrate
Methohexital may increase the hypotensive activities of Isosorbide Mononitrate.
Isoxsuprine
Methohexital may increase the hypotensive activities of Isoxsuprine.
Isradipine
The metabolism of Isradipine can be increased when combined with Methohexital.
Ketamine
The risk or severity of adverse effects can be increased when Methohexital is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Methohexital is combined with Ketazolam.
Labetalol
The serum concentration of Labetalol can be decreased when it is combined with Methohexital.
Lacidipine
The metabolism of Lacidipine can be increased when combined with Methohexital.
Lamotrigine
The serum concentration of Lamotrigine can be decreased when it is combined with Methohexital.
Lercanidipine
The metabolism of Lercanidipine can be increased when combined with Methohexital.
Levetiracetam
The risk or severity of adverse effects can be increased when Methohexital is combined with Levetiracetam.
Levobetaxolol
The serum concentration of Levobetaxolol can be decreased when it is combined with Methohexital.
Levobunolol
The serum concentration of Levobunolol can be decreased when it is combined with Methohexital.
Levobupivacaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Methohexital is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Methohexital is combined with Levocetirizine.
Levodopa
Methohexital may increase the hypotensive activities of Levodopa.
LEVOMENTHOL
The metabolism of Menthol can be increased when combined with Methohexital.
Levomethadyl
The risk or severity of adverse effects can be increased when Methohexital is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Methohexital is combined with Levomilnacipran.
Levonorgestrel
The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Methohexital.
Levorphanol
The risk or severity of adverse effects can be increased when Methohexital is combined with Levorphanol.
Levosimendan
Methohexital may increase the hypotensive activities of Levosimendan.
Lidocaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Lidocaine.
Lisinopril
Methohexital may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Methohexital may increase the hypotensive activities of Lisinopril.
Lithium
The risk or severity of adverse effects can be increased when Methohexital is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Methohexital is combined with Lithium.
Lofexidine
The therapeutic efficacy of Methohexital can be increased when used in combination with Lofexidine.
Loperamide
The metabolism of Loperamide can be increased when combined with Methohexital.
Loratadine
The risk or severity of adverse effects can be increased when Methohexital is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Methohexital.
Lormetazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Lormetazepam.
Losartan
Methohexital may increase the hypotensive activities of Losartan.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Methohexital.
Lurasidone
The risk or severity of adverse effects can be increased when Methohexital is combined with Lurasidone.
Lynestrenol
The therapeutic efficacy of Lynestrenol can be decreased when used in combination with Methohexital.
Magnesium Sulfate
The therapeutic efficacy of Methohexital can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Methohexital can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Manidipine can be increased when combined with Methohexital.
Mannitol
Methohexital may increase the hypotensive activities of Mannitol.
Maprotiline
The risk or severity of adverse effects can be increased when Methohexital is combined with Maprotiline.
Mecamylamine
Methohexital may increase the hypotensive activities of Mecamylamine.
Meclizine
The risk or severity of adverse effects can be increased when Methohexital is combined with Meclizine.
Medrogestone
The serum concentration of Medrogestone can be decreased when it is combined with Methohexital.
Medroxyprogesterone Acetate
The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Methohexital.
Megestrol Acetate
The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Methohexital.
Melatonin
The risk or severity of adverse effects can be increased when Methohexital is combined with Melatonin.
MELITRACEN
The metabolism of Melitracen can be increased when combined with Methohexital.
Menthol
The metabolism of Menthol can be increased when combined with Methohexital.
Meperidine
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Mephobarbital
The risk or severity of adverse effects can be increased when Methohexital is combined with Methylphenobarbital.
Mepindolol
The serum concentration of Mepindolol can be decreased when it is combined with Methohexital.
Mepirodipine
The metabolism of Barnidipine can be increased when combined with Methohexital.
Mepivacaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Methohexital.
Mesoridazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Mesoridazine.
Mestranol
The therapeutic efficacy of Mestranol can be decreased when used in combination with Methohexital.
Metaxalone
The risk or severity of adverse effects can be increased when Methohexital is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Methohexital.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methohexital is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Methohexital is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Methohexital is combined with Methaqualone.
Methazolamide
Methohexital may increase the hypotensive activities of Methazolamide.
Methocarbamol
The risk or severity of adverse effects can be increased when Methohexital is combined with Methocarbamol.
Methotrimeprazine
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Methohexital is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Methohexital is combined with Methsuximide.
Methyclothiazide
Methohexital may increase the orthostatic hypotensive activities of Methyclothiazide.
Methyldopa
Methohexital may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Methohexital may increase the hypotensive activities of Methyldopa.
Metipranolol
The serum concentration of Metipranolol can be decreased when it is combined with Methohexital.
Metolazone
Methohexital may increase the orthostatic hypotensive activities of Metolazone.
Metoprolol
The serum concentration of Metoprolol can be decreased when it is combined with Methohexital.
Metylperon
The risk or severity of adverse effects can be increased when Methohexital is combined with Melperone.
Metyrosine
Methohexital may increase the sedative activities of Metyrosine.
Mianserin
Mianserin may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Mibefradil
The metabolism of Mibefradil can be increased when combined with Methohexital.
Midazolam
The risk or severity of adverse effects can be increased when Methohexital is combined with Midazolam.
Milnacipran
The risk or severity of adverse effects can be increased when Methohexital is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Minoxidil
Methohexital may increase the hypotensive activities of Minoxidil.
Mirtazapine
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moexipril
Methohexital may increase the hypotensive activities of Moexipril.
Molindone
The risk or severity of adverse effects can be increased when Methohexital is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Methohexital.
Moxonidine
Methohexital may increase the hypotensive activities of Moxonidine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Nadolol
The serum concentration of Nadolol can be decreased when it is combined with Methohexital.
Nalbuphine
The risk or severity of adverse effects can be increased when Methohexital is combined with Nalbuphine.
Nebivolol
The serum concentration of Nebivolol can be decreased when it is combined with Methohexital.
Nefazodone
The risk or severity of adverse effects can be increased when Methohexital is combined with Nefazodone.
Nesiritide
Methohexital may increase the hypotensive activities of Nesiritide.
Nicardipine
The metabolism of Nicardipine can be increased when combined with Methohexital.
Nifedipine
The metabolism of Nifedipine can be increased when combined with Methohexital.
Nilvadipine
The metabolism of Nilvadipine can be increased when combined with Methohexital.
Nimesulide
The metabolism of Nimesulide can be increased when combined with Methohexital.
Nimodipine
The metabolism of Nimodipine can be increased when combined with Methohexital.
Nisoldipine
The metabolism of Nisoldipine can be increased when combined with Methohexital.
Nitrazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Nitrazepam.
Nitrendipine
The metabolism of Nitrendipine can be increased when combined with Methohexital.
Nitric Oxide
Methohexital may increase the hypotensive activities of Nitric Oxide.
Nitroglycerin
Methohexital may increase the hypotensive activities of Nitroglycerin.
Nitroprusside
Methohexital may increase the hypotensive activities of Nitroprusside.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Methohexital is combined with Nitrous oxide.
Nomegestrol Acetate
The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Methohexital.
Nordazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Nordazepam.
Norelgestromin
The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Methohexital.
Norethindrone
The therapeutic efficacy of Norethisterone can be decreased when used in combination with Methohexital.
Norethynodrel
The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Methohexital.
Norflurane
The risk or severity of adverse effects can be increased when Methohexital is combined with Norflurane.
Norgestimate
The therapeutic efficacy of Norgestimate can be decreased when used in combination with Methohexital.
Norgestrel
The therapeutic efficacy of Norgestrel can be decreased when used in combination with Methohexital.
Normethadone
The risk or severity of adverse effects can be increased when Methohexital is combined with Normethadone.
Nortriptyline
The metabolism of Nortriptyline can be increased when combined with Methohexital.
Nylidrin
The metabolism of Nylidrin can be increased when combined with Methohexital.
Obinutuzumab
Methohexital may increase the hypotensive activities of Obinutuzumab.
Octylonium
The metabolism of Otilonium can be increased when combined with Methohexital.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Methohexital.
Olmesartan
Methohexital may increase the hypotensive activities of Olmesartan.
Olopatadine
The risk or severity of adverse effects can be increased when Methohexital is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Methohexital is combined with Ondansetron.
Opipramol
The metabolism of Opipramol can be increased when combined with Methohexital.
Opium
The risk or severity of adverse effects can be increased when Methohexital is combined with Opium.
Orphenadrine
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Oxazepam.
Oxprenolol
The risk or severity of adverse effects can be increased when Methohexital is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Methohexital is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Methohexital is combined with Oxymorphone.
Paclitaxel
Methohexital may increase the hypotensive activities of Paclitaxel.
Paliperidone
The risk or severity of adverse effects can be increased when Methohexital is combined with Paliperidone.
Papaverine
Methohexital may increase the hypotensive activities of Papaverine.
Paraldehyde
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Methohexital.
Paroxetine
The risk or severity of adverse effects can be increased when Methohexital is combined with Paroxetine.
Penbutolol
The serum concentration of Penbutolol can be decreased when it is combined with Methohexital.
Pentazocine
The risk or severity of adverse effects can be increased when Methohexital is combined with Pentazocine.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Methohexital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Perazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Perazine.
Perindopril
Methohexital may increase the hypotensive activities of Perindopril.
Perphenazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Perphenazine.
Phenelzine
Methohexital may increase the hypotensive activities of Phenelzine.
Phenindione
The metabolism of Phenindione can be increased when combined with Methohexital.
Phenobarbital
The risk or severity of adverse effects can be increased when Methohexital is combined with Phenobarbital.
Phenoxybenzamine
Methohexital may increase the hypotensive activities of Phenoxybenzamine.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Methohexital is combined with Phenoxyethanol.
Phenprocoumon
The metabolism of Phenprocoumon can be increased when combined with Methohexital.
Phentolamine
Methohexital may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Methohexital may increase the hypotensive activities of Phentolamine.
Phenytoin
The risk or severity of adverse effects can be increased when Methohexital is combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Methohexital is combined with Pimozide.
Pinaverium
The metabolism of Pinaverium can be increased when combined with Methohexital.
Pindolol
The serum concentration of Pindolol can be decreased when it is combined with Methohexital.
Pipamperone
The risk or severity of adverse effects can be increased when Methohexital is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Methohexital is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Methohexital is combined with Pizotifen.
Polythiazide
Methohexital may increase the orthostatic hypotensive activities of Polythiazide.
Pomalidomide
The risk or severity of adverse effects can be increased when Methohexital is combined with Pomalidomide.
Practolol
The serum concentration of Practolol can be decreased when it is combined with Methohexital.
Pramipexole
Methohexital may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Methohexital is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Prazepam.
Prazosin
Methohexital may increase the hypotensive activities of Prazosin.
Pregabalin
The therapeutic efficacy of Methohexital can be increased when used in combination with Pregabalin.
Prenylamine
The metabolism of Prenylamine can be increased when combined with Methohexital.
Prilocaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Prilocaine.
Primidone
The risk or severity of adverse effects can be increased when Primidone is combined with Methohexital.
Procaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Methohexital.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Methohexital.
Promethazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Promethazine.
Propafenone
The serum concentration of Propafenone can be decreased when it is combined with Methohexital.
Proparacaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Methohexital is combined with Propofol.
Propoxyphene
The risk or severity of adverse effects can be increased when Methohexital is combined with Dextropropoxyphene.
Propranolol
The serum concentration of Propranolol can be decreased when it is combined with Methohexital.
Protriptyline
The metabolism of Protriptyline can be increased when combined with Methohexital.
Pyridoxine
The metabolism of Methohexital can be increased when combined with Pyridoxine.
Quazepam
The risk or severity of adverse effects can be increased when Methohexital is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Methohexital is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Methohexital is combined with Quetiapine.
Quinapril
Methohexital may increase the hypotensive activities of Quinapril.
Quinethazone
Methohexital may increase the orthostatic hypotensive activities of Quinethazone.
Ramelteon
The risk or severity of adverse effects can be increased when Methohexital is combined with Ramelteon.
Ramipril
Methohexital may increase the hypotensive activities of Ramipril.
Rasagiline
Methohexital may increase the hypotensive activities of Rasagiline.
Remifentanil
The risk or severity of adverse effects can be increased when Methohexital is combined with Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Methohexital is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Methohexital.
Rifabutin
The metabolism of Methohexital can be increased when combined with Rifabutin.
Rifampin
The metabolism of Methohexital can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Methohexital can be increased when combined with Rifapentine.
Rifaximin
The metabolism of Methohexital can be increased when combined with Rifaximin.
Riociguat
Methohexital may increase the hypotensive activities of Riociguat.
Risperidone
The risk or severity of adverse effects can be increased when Methohexital is combined with Risperidone.
Ropinirole
Methohexital may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Ropivacaine.
Rotigotine
Methohexital may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Methohexital.
Sacubitril
Methohexital may increase the hypotensive activities of Sacubitril.
Scopolamine
The risk or severity of adverse effects can be increased when Methohexital is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Methohexital is combined with Scopolamine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Methohexital.
Selegiline
Methohexital may increase the hypotensive activities of Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Methohexital is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Methohexital is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Methohexital is combined with Sevoflurane.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Somatostatin
The risk or severity of adverse effects can be increased when Somatostatin is combined with Methohexital.
Sotalol
The serum concentration of Sotalol can be decreased when it is combined with Methohexital.
Spironolactone
Methohexital may increase the hypotensive activities of Spironolactone.
Streptokinase
Methohexital may increase the hypotensive activities of Streptokinase.
Sufentanil
The risk or severity of adverse effects can be increased when Methohexital is combined with Sufentanil.
Sulpiride
The risk or severity of adverse effects can be increased when Methohexital is combined with Sulpiride.
Suvorexant
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Talinolol
The serum concentration of Talinolol can be decreased when it is combined with Methohexital.
Tamsulosin
Methohexital may increase the hypotensive activities of Tamsulosin.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Tasimelteon
The risk or severity of adverse effects can be increased when Methohexital is combined with Tasimelteon.
Telmisartan
Methohexital may increase the hypotensive activities of Telmisartan.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Methohexital.
Teniposide
The serum concentration of Teniposide can be decreased when it is combined with Methohexital.
Terazosin
Methohexital may increase the hypotensive activities of Terazosin.
Terbutaline
The serum concentration of Terbutaline can be decreased when it is combined with Methohexital.
Terbutaline Sulfate
The serum concentration of Terbutaline can be decreased when it is combined with Methohexital.
Tertatolol
The serum concentration of Tertatolol can be decreased when it is combined with Methohexital.
Tetrabenazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Methohexital is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Methohexital is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Thalidomide
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The serum concentration of Theophylline can be decreased when it is combined with Methohexital.
Theophylline anhydrous
The serum concentration of Theophylline can be decreased when it is combined with Methohexital.
Thiamylal
The risk or severity of adverse effects can be increased when Methohexital is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Methohexital is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Methohexital is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Methohexital is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Methohexital is combined with Tiagabine.
Tianeptine
The metabolism of Tianeptine can be increased when combined with Methohexital.
Tiapride
The risk or severity of adverse effects can be increased when Methohexital is combined with Tiapride.
Timolol
The serum concentration of Timolol can be decreased when it is combined with Methohexital.
Timolol Anhydrous
The serum concentration of Timolol can be decreased when it is combined with Methohexital.
Tizanidine
The risk or severity of adverse effects can be increased when Methohexital is combined with Tizanidine.
Tolazoline
Methohexital may increase the hypotensive activities of Tolazoline.
Tolcapone
Methohexital may increase the hypotensive activities of Tolcapone.
Tolfenamic Acid
The metabolism of Tolfenamic Acid can be increased when combined with Methohexital.
Topiramate
The risk or severity of adverse effects can be increased when Methohexital is combined with Topiramate.
Torsemide
Methohexital may increase the hypotensive activities of Torasemide.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Methohexital.
Trandolapril
Methohexital may increase the hypotensive activities of Trandolapril.
Tranilast
The metabolism of Tranilast can be increased when combined with Methohexital.
Tranylcypromine
The risk or severity of adverse effects can be increased when Methohexital is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Methohexital is combined with Trazodone.
Tretinoin
Methohexital may increase the hypotensive activities of Tretinoin.
Triamterene
Methohexital may increase the hypotensive activities of Triamterene.
Triazolam
The risk or severity of adverse effects can be increased when Methohexital is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Methohexital is combined with Loprazolam.
Trichlormethiazide
Methohexital may increase the orthostatic hypotensive activities of Trichlormethiazide.
Trifluoperazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Triflupromazine.
Trimebutine
The metabolism of Trimebutine can be increased when combined with Methohexital.
Trimethadione
The metabolism of Trimethadione can be increased when combined with Methohexital.
Trimipramine
The metabolism of Trimipramine can be increased when combined with Methohexital.
Triprolidine
The risk or severity of adverse effects can be increased when Methohexital is combined with Triprolidine.
Ulipristal
The serum concentration of Ulipristal can be decreased when it is combined with Methohexital.
Urethane
The risk or severity of adverse effects can be increased when Methohexital is combined with Ethyl carbamate.
Valproate
The serum concentration of Methohexital can be increased when it is combined with Valproic Acid.
Valproic Acid
The serum concentration of Methohexital can be increased when it is combined with Valproic Acid.
Valsartan
Methohexital may increase the hypotensive activities of Valsartan.
Venlafaxine
The risk or severity of adverse effects can be increased when Methohexital is combined with Venlafaxine.
Verapamil
The metabolism of Verapamil can be increased when combined with Methohexital.
Vigabatrin
The risk or severity of adverse effects can be increased when Methohexital is combined with Vigabatrin.
Vinpocetine
The metabolism of Vinpocetine can be increased when combined with Methohexital.
Vitamin B6
The metabolism of Methohexital can be increased when combined with Pyridoxine.
Voriconazole
The serum concentration of Voriconazole can be decreased when it is combined with Methohexital.
Vortioxetine
The risk or severity of adverse effects can be increased when Methohexital is combined with Vortioxetine.
Warfarin
The metabolism of Warfarin can be increased when combined with Methohexital.
Xylazine
The risk or severity of adverse effects can be increased when Methohexital is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Methohexital is combined with Zaleplon.
Ziconotide
The metabolism of Ziconotide can be increased when combined with Methohexital.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Methohexital.
Zolpidem
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Methohexital is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Methohexital is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Methohexital is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Methohexital is combined with Zuclopenthixol.
